Clinical Trials Search Results

Results 21-30 of 274 for your search
Show Search Criteria
Lenvatinib and pembrolizumab in DTC
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 7 locations
PEN-221 in Somatostatin Receptor 2 Expressing Advanced Cancers Including Neuroendocrine and Small Cell Lung Cancers
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 7 locations
Safety Study of Enoblituzumab (MGA271) in Combination With Pembrolizumab or MGA012 in Refractory Cancer
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 7 locations
TTX-030 Single Agent and in Combination With Immunotherapy or Chemotherapy for Patients With Advanced Cancers
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 7 locations
Treatment of Radiation and Cisplatin Induced Toxicities With Tempol
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 6 locations
Dose-Escalation and Dose-Expansion of RMC-4630 and Cobimetinib in Relapsed / Refractory Solid Tumors
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 8 locations
Study of IMMU-132 in HR+ / HER2- MBC (TROPICS-02)
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 11 locations
Efficacy & Safety of rAd-IFN Administered With Celecoxib & Gemcitabine in Patients With Malignant Pleural Mesothelioma
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 7 locations